Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
To determine demographic and clinical variables associated with inhaled corticosteroid administration and to evaluate between-hospital variation in inhaled steroid use for infants with bronchopulmonary dysplasia (BPD).Retrospective Cohort Study.Neonatal units of 35 US children's hospitals; as r...
Main Authors: | Jonathan L Slaughter, Michael R Stenger, Patricia B Reagan, Sudarshan R Jadcherla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4156388?pdf=render |
Similar Items
-
Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions.
by: Brian J Clouse, et al.
Published: (2016-01-01) -
Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
by: Leif D. Nelin, et al.
Published: (2022-07-01) -
Response of Very Premature Infants with Bronchopulmonary Dysplasia to Inhaled Salbutamol
by: Ha-Nam Nguyen, et al.
Published: (2020-12-01) -
Reviewing the use of corticosteroids in bronchopulmonary dysplasia
by: Fernanda Aparecida de Oliveira Peixoto, et al.
Published: (2016-03-01) -
Reviewing the use of corticosteroids in bronchopulmonary dysplasia
by: Fernanda Aparecida de Oliveira Peixoto, et al.
Published: (2016-04-01)